Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Atossa Genetics Inc. (ATOS) had Non-Operating Income/Expense of $0.50M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.94M |
|
-- |
|
-- |
|
$11.44M |
|
$-11.44M |
|
|
Non-Operating Income/Expense |
$0.50M |
$-10.94M |
|
$-10.94M |
|
$-10.94M |
|
$-10.94M |
|
$-10.94M |
|
$-10.94M |
|
$-11.44M |
|
$-11.43M |
|
8.61M |
|
8.61M |
|
$-1.19 |
|
$-1.19 |
|
| Balance Sheet Financials | |
$45.62M |
|
-- |
|
$1.99M |
|
$47.61M |
|
$8.26M |
|
-- |
|
-- |
|
$8.26M |
|
$39.35M |
|
$39.35M |
|
$39.35M |
|
8.61M |
|
| Cash Flow Statement Financials | |
$-29.76M |
|
$-0.02M |
|
-- |
|
$71.19M |
|
$41.41M |
|
$-29.79M |
|
$2.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.79% |
|
-27.79% |
|
-22.97% |
|
-27.79% |
|
$4.57 |
|
$-3.46 |
|
$-3.46 |
|